Study Completed

Atopic dermatitis

Bayer Identifier:

1400402

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Dermatology II

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

12 Years

Trial summary

Enrollment Goal

249

Trial Dates

July 2005 - June 2006

Phase

Phase 4

Could I Receive a placebo

N/A

Products

Advantan (Methylprednisolone Aceponate, BAY86-4862)

Accepts Healthy Volunteer

N/A

Trial design

Double-blind, placebo-controlled, randomized, multicenter, parallel-group study to compare the efficacy and safety of Advantan cream twice weekly with Advabasecream during a maintenance phase of 16 weeks after successful treatment of atopic dermatitis with Advantan cream

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.